Pfizer’s vaccine, known as Comirnaty, was the first COVID vaccine approved on an emergency basis in the U.S., and in nearly two years since its approval, it has been given hundreds of millions of times. But the other mRNA vaccine, which was authorized in the U.S. several weeks later, was based on the same technology and Pfizer didn’t have the right to use it, Moderna argues.
“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic,” said Stéphane Bancel, chief executive officer of Moderna. “This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck.”
“As we work to combat health challenges moving forward, Moderna is using our mRNA technology platform to develop medicines that could treat and prevent infectious diseases like influenza and HIV, as well as autoimmune and cardiovascular diseases and rare forms of cancer,” he said.
The Daily Wire has reached out to Pfizer for comment.
This is a developing story; refresh the page for updates.